BIOPTIMATE ApS: Financial statements 2018
CVR: 36051183
BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 12,582 and a net result of DKK 12,986 compared with DKK -24,306 the year before. Equity amounted to DKK 87,916. The solvency ratio was 82.7%.
- Gross Profit
- 12,582 kr.
- Profit/Loss
- 12,986 kr.
- Equity
- 87,916 kr.
- Total Assets
- 106,333 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 13 t. | 13 t. | 88 t. | - |
| 2017 | - | -20 t. | -24 t. | 75 t. | - |
| 2016 | - | -13 t. | 39 t. | 99 t. | - |
Keep an eye on BIOPTIMATE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
BIOPTIMATE ApS has published its annual report for 2017. Gross profit came to DKK -19,801, and the net result was DKK -24,306.
About BIOPTIMATE ApS
BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2024, the company reported a gross profit of DKK -2,075,727 and a net result of DKK -6,367,118 compared with DKK -4,997,291 the year before. Equity amounted to DKK -3,855,665.
